Pulse Biosciences Incの価格/簿価
Pulse Biosciences Incの価格/簿価は何ですか。
Pulse Biosciences Incの価格/簿価は2.43です。
価格/簿価の定義は何ですか。
株価純資産倍率は、会社の株価と1株当たりの簿価との比率を表します。
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
NASDAQのセクタHealth Careにおける価格/簿価の企業と比べるPulse Biosciences Inc
Pulse Biosciences Incは何をしますか。
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Pulse Biosciences Incと類似の価格/簿価
- Telefonaktiebolaget LM Ericssonの価格/簿価は2.42です。
- UCWの価格/簿価は2.42です。
- Axis Auto Finance Incの価格/簿価は2.42です。
- Heidelberg Pharma AGの価格/簿価は2.42です。
- Spectrum Pharmaceuticalsの価格/簿価は2.43です。
- ECN Capitalの価格/簿価は2.43です。
- Pulse Biosciences Incの価格/簿価は2.43です。
- BOE Varitronixの価格/簿価は2.43です。
- Savariaの価格/簿価は2.43です。
- CPS Technologiesの価格/簿価は2.43です。
- Microbix Biosystemsの価格/簿価は2.43です。
- Cassius Miningの価格/簿価は2.43です。
- Genfit SAの価格/簿価は2.43です。